Aortic Valve Stenosis: all 1,006 studies

Page 6 of 11. Open to participants first (284), then studies with results posted, then the rest; newest registration first within each.

• Novel Echocardiographic and Invasive Haemodynamic Measurements in the Assessment of Patients Low Flow Low Gradient Aortic Stenosis Undergoing TAVICompletedNCT05196815Not applicable
• Transcatheter Aortic Valve Replacement (TAVR) Double Balloon ValvuloplastyStatus unknownNCT05189886
• DurAVR™ THV System: EMBARK StudyActive, not recruitingNCT05182307Not applicable
• MRI in Randomised Cohorts of Asymptomatic ASCompletedNCT05178368
• China S3 PMS: SAPIEN 3 China Post Market Registry StudyActive, not recruitingNCT05168826
• Colchicine and Inflammation in Aortic StenosisActive, not recruitingNCT05162742Phase 3
• INTERvention With Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation (INTERCEPTavi)Status unknownNCT05146037Not applicable
• Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve ImplantationCompletedNCT05145283Phase 2
• Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve ImplantationStatus unknownNCT05097183
• The SAVVY Guidewire in Transcatheter Aortic Valve Replacement ProceduresCompletedNCT05082337Not applicable
• Percutaneous Coronary Intervention Before Transcatheter Aortic Valve ImplantationActive, not recruitingNCT05078619Not applicable
• OpSens PRIME CLASSTerminatedNCT05070130
• Anxiety Reduction in TAVI Using Virtual Reality TrialStatus unknownNCT05069987Not applicable
• Brain Lesions After Transcatheter Aortic Valve ReplacementStatus unknownNCT05065697
• The Leaflex™ Brazilian Standalone StudyTerminatedNCT05052684Not applicable
• RanDOmized stUdy Comparing Both Latest Generation Self-Expanding Valves and a Minimalist approaCH vs. Standard Of Care In transCathEter Aortic Valve ImplantationActive, not recruitingNCT05036018Not applicable
• AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve ImplantationCompletedNCT05035277Phase 3
• LUS in Aortic Stenosis Patients Undergoing TAVRStatus unknownNCT05024942
• Left Bundle Branch Area Pacing in Patients After TAVRStatus unknownNCT05024279Not applicable
• Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic StenosisStatus unknownNCT05015829
• Early Detection of Cardiac AmyloidosisStatus unknownNCT05010980
• On Dose Efficiency of Modern CT-scanners in Chest ScansCompletedNCT04996693Not applicable
• Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction SystemCompletedNCT04982406
• NIRS-IVUS to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve ImplantationStatus unknownNCT04976062
• Use of Virtual Reality for Procedural Planning of Transcatheter Aortic Valve ReplacementCompletedNCT04944667Not applicable
• Coronary Artery Disease in Elderly People Referred for TAVIStatus unknownNCT04930510
• TAVI and Gender Outcomes Aortic Stenosis Undergoing Transfemoral Transcatheter Aortic Valve Implantation.SuspendedNCT04915976
• Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic StenosisCompletedNCT04899180Early Phase 1
• Screening for Amyloidosis Before Aortic Valve Elective ReplacementActive, not recruitingNCT04869631
• PrizValve® Transcatheter Aortic Valve Replacement StudyActive, not recruitingNCT04836897Not applicable
• Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR)CompletedNCT04827238
• Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic StenosisActive, not recruitingNCT04815785Not applicable
• Early neo2 Registry of the Acurate neo2 TAVI ProsthesisCompletedNCT04810195
• IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVIStatus unknownNCT04797832Phase 4
• Understanding Patient Goals and Preferences to Facilitate Shared Decision Making for Symptomatic Aortic StenosisCompletedNCT04755426
• Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve Replacement System With Retrievable Delivery Catheter SystemCompletedNCT04744857Not applicable
• Myeloid Cells in Aortic Valve StenosisStatus unknownNCT04717219
• Comparison of Aorto-iliac Endovascular Interventions With and Without the EndoNaut WorkstationStatus unknownNCT04714268
• NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection DeviceCompletedNCT04704258Not applicable
• Dapagliflozin After Transcatheter Aortic Valve ImplantationCompletedNCT04696185Phase 4
• Romanian National Registry of Outcomes After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis - RO-TAVIStatus unknownNCT04694859
• Cerebral Lesion and Neurocognitive Status Changes After TAVRStatus unknownNCT04678934
• Valvosoft First-In-Human Study in Severe Symptomatic Aortic StenosisCompletedNCT04665596Not applicable
• Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular ComorbiditiesCompletedNCT04663334
• VitaFlow™ Transcatheter Aortic Valve System Pre-market TrialStatus unknownNCT04655742Not applicable
• ACURATE neo2™ Post Market Clinical Follow up StudyActive, not recruitingNCT04655248
• The Leaflex™ Standalone Study ProtocolTerminatedNCT04649099Not applicable
• The Leaflex™ Early Feasibility StudyWithdrawnNCT04636073Not applicable
• Parasternal vs. Sternotomy Approach for Conventional Aortic Valve ReplacementStatus unknownNCT04632095Not applicable
• Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE StenosisCompletedNCT04613193Not applicable
• Validation of a Novel, Non-Dimensional Approach for Estimation of Pressure Gradients in Aortic StenosisStatus unknownNCT04600739
• transShield Embolic Protection System Feasibility StudyCompletedNCT04585308Not applicable
• The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve ReplacementStatus unknownNCT04573049Phase 4
• Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart DiseaseCompletedNCT04571372
• Impact of Pre-procedure Cognitive Status on Outcome at 3 Months After Transcatheter Aortic Valve ImplantationCompletedNCT04564534
• Evaluation of the Inflammatory Response in Post-operated Aortic Valve Replacement Patients.CompletedNCT04557345
• SAPIEN 3 Ultra System PMCFActive, not recruitingNCT04555967
• Hemodynamic Matched Comparison of the Balloon-Expandable Transcatheter Heart Valves Myval and Sapien-3 for the Treatment of Aortic StenosisCompletedNCT04548726
• Epidemiology and Long-term Outcome of Patients With VHDCompletedNCT04527367
• Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular DiseaseStatus unknownNCT04525937
• Early Outcomes of Concomitant Transcatheter Aortic Valve Implantation and Off-pump Coronary Artery Bypass Grafting in Management of Severe Symptomatic Aortic Stenosis and Coronary Artery DiseaseStatus unknownNCT04525339
• Stress Aortic Valve Index for Assessing Risk in Aortic Valve Stenosis PatientsActive, not recruitingNCT04514250
• Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve ImplantationCompletedNCT04503655Not applicable
• Non-contrast 3-dimensional Cardiac Magnetic Resonance ImagingCompletedNCT04496297
• Conduction Disease After Transcatheter Aortic Valve ReplacementCompletedNCT04489095Not applicable
• Addition of Computer Simulations to Minimize Adverse Events After Transcatheter Aortic Valve ImplantationStatus unknownNCT04473443
• Comparison of Spectral Photon Counting CT (SPCCT) With Dual Energy CT (DECT) and Magnetic Resonance Imaging (MRI) for Plaque and Lumen Carotid Arteries EvaluationCompletedNCT04466787Not applicable
• Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve ImplantationCompletedNCT04459208Not applicable
• Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)CompletedNCT04437303Phase 4
• SLOW-Slower Progress of caLcificatiOn With Vitamin K2Status unknownNCT04429035Not applicable
• Transcatheter Aortic Valve Implantation in Western NORwayCompletedNCT04417829
• TMAO in Patients With Severe Aortic StenosisStatus unknownNCT04406805
• Development of an Algorithm to Differentiate Heart Murmurs Using Electronic StethoscopesCompletedNCT04400513
• Vascular Closure Device in Transcatheter Aortic Valve ReplacementStatus unknownNCT04392492
• Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic SurgeryStatus unknownNCT04388267
• Severe Aortic Valve Stenosis and Concomitant Coronary Artery Disease in Patients Undergoing TAVICompletedNCT04385459
• Supra-Annular vs. Annular ValvEs for Small AnnuliWithdrawnNCT04372381Not applicable
• Targeted Testing for ATTR Among Aortic Stenosis Patients-PilotWithdrawnNCT04363294Not applicable
• Measurement of Myocardial Stiffness Using Elastometry in Patients With Aortic StenosisCompletedNCT04358692Not applicable
• TAVR Without PredilatationStatus unknownNCT04350658
• Sedation or General Anesthesia During TAVRCompletedNCT04347603Not applicable
• Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve ImplantationStatus unknownNCT04346004Phase 4
• Analysis and Comparative Evaluation of Aortic Calcium by Computed Tomography and Histopathology in Patients With Aortic StenosisCompletedNCT04344353
• Follow-up After TAVR Without Systematic Intensive Care Unit AdmissionStatus unknownNCT04335149
• Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic StenosisCompletedNCT04333875
• Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI TrialActive, not recruitingNCT04310046Not applicable
• Spanish Percutaneous Aortic INtervention REGISTRY (SPAIN REGISTRY)Status unknownNCT04307888
• Improved HRV, Inflammation Markers and Endothelial Function After TAVICompletedNCT04286893
• Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRIActive, not recruitingNCT04281771Not applicable
• Comparison of Transaxillary and Transfemoral Fully-percutaneous Approaches for Transcatheter Aortic Valve ImplantationCompletedNCT04274751
• GPx Activity in Subjects With Aortic Stenosis Undergoing TAVRWithdrawnNCT04268160
• Virtual Reality Assisted Conscious Sedation During TAVICompletedNCT04259723Not applicable
• Accuracy of Using 2D Transesophageal Echocardiography Compared to Balloon Sizing in Determining Valve Size During Transcatheter Aortic Valve ImplantationStatus unknownNCT04242225
• Quality of Life After Cardiac SurgeryCompletedNCT04231461
• Aortic Stenosis Evaluated Via Modern Ballistocardiography and SeismocardiographySuspendedNCT04231201
• Elimination of CO2-insufflation-induced Hypercarbia in Open Heart SurgeryStatus unknownNCT04202575Not applicable
• First in Human Feasibility Study With ADAPT 3D - ALR for Aortic Leaflet RepairStatus unknownNCT04178213Not applicable
• Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve ImplantationStatus unknownNCT04171726Phase 3
• Impact of Home-based Cardiac Rehabilitation on Outcomes After TAVRStatus unknownNCT04166682Not applicable
• Transcatheter Aortic Valve Replacement With Extracorporeal Life System SupportStatus unknownNCT04160624Not applicable

← Aortic Valve Stenosis overview